PHARMACEUTICAL CARE FOR PATIENTS ON HERCEPTIN® (TRANSTUZUMAB): CASE REPORT
DOI:
https://doi.org/10.14450/2318-9312.v32.e1.a2020.pp23-29Keywords:
pharmaceutical care, antineoplasic agents, health education, medication adherenceAbstract
Pharmaceutical care can contribute to the patient’s well‑being throughout the therapy and for medication adherence. This practice is based on the theoretical framework of Pharmaceutical Care that proposes a patient‑centered approach focused on the prevention, identification and resolution of drug therapy problems to promote positive results in people’s health. The present study aims to report the pharmaceutical care to patients treated with Herceptin® (trastuzumab) at an oncology clinic in Rio de Janeiro, Brazil. Four patients were followed during four months in 2016. The main drug‑related problem identified was adverse drug reactions. Pharmaceutical interventions were performed with patients and prescribers. The most frequent interventions were education about the disease and the treatment. Educational interventions have helped to improve patients’ understanding of the disease and treatment, contributing to pharmacotherapy adherence. The present study highlights the importance of pharmaceutical care and supports to improve the quality of life of patients followed.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
- Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).